Trimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
16 Junio 2014 - 2:20PM
Marketwired
Trimel to Present at the 2014 Bloom Burton & Co. Healthcare
Investor Conference
TORONTO, ONTARIO--(Marketwired - Jun 16, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) today announced that
management is scheduled to present an overview of the Company at
the 2014 Bloom Burton & Co. Healthcare Investor Conference at
the Toronto Board of Trade on June 18th, 2014 at 2:30 p.m. (Eastern
time). The presentation materials will also be made available on
the Trimel website at www.trimelpharmaceuticals.com.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. Natesto™, a product utilizing
Trimel's licensed bioadhesive nasal gel technology, has been
approved for sale in the United States by the FDA. For more
information, please visit www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial
Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Trilogy International Pa... (TSX:TRL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Trilogy International Pa... (TSX:TRL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Trilogy International Partners Inc (Toronto Stock Exchange): 0 recent articles
Más de Trimel Pharmaceuticals Corp Artículos de Noticias